Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for AGIO

Stock Name	Agios Pharm
Ticker	AGIO(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US00847X1046
LEI	529900ONJHY8EOGYT555

Show aggregate AGIO holdings

News associated with AGIO

AGIO Crosses Below Key Moving Average Level: In trading on Thursday, shares of Agios Pharmaceuticals Inc (Symbol: AGIO) crossed below their 200 day moving average of $35.78, changing hands as low as $32.70 per share. Agios Pharmaceuticals Inc shares are currently trading down about 14.2% on the day. The chart below shows - 2025-09-04 12:41:27
Deutsche Bank AG Lowers Stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO): Deutsche Bank AG decreased its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) by 0.7% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 928,970 shares of the biopharmaceutical company’s stock after selling 6,282 shares during the quarter. Deutsche Bank AG’s […] - 2025-08-13 05:20:52
Monday's ETF Movers: SPXL, BBSC: In trading on Monday, the Direxion Daily S&P 500 Bull 3X ETF is outperforming other ETFs, up about 3.5% on the day. Components of that ETF showing particular strength include shares of Idexx Laboratories, up about 26.2% and shares of Martin Marietta Materials, up about 5.1% - 2025-08-04 13:04:13
Agios Pharmaceuticals Becomes Oversold (AGIO): Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me - 2025-08-04 12:58:40
Agios Pharmaceuticals (AGIO) Shares Cross Below 200 DMA: In trading on Thursday, shares of Agios Pharmaceuticals Inc (Symbol: AGIO) crossed below their 200 day moving average of $36.97, changing hands as low as $35.81 per share. Agios Pharmaceuticals Inc shares are currently trading down about 0.6% on the day. The chart below shows - 2025-07-31 14:21:35
Bullish Two Hundred Day Moving Average Cross - AGIO: In trading on Wednesday, shares of Agios Pharmaceuticals Inc (Symbol: AGIO) crossed above their 200 day moving average of $37.36, changing hands as high as $38.82 per share. Agios Pharmaceuticals Inc shares are currently trading up about 6.6% on the day. The chart below shows - 2025-07-09 12:42:52
Analysts Set Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Price Target at $58.60: Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) have been assigned an average rating of “Moderate Buy” from the seven research firms that are presently covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12-month […] - 2025-07-02 03:14:49
Agios' PYRUKYND Faces FDA Review In September - Expansion Opportunity Ahead?: (RTTNews) - Shares of Agios Pharmaceuticals Inc. (AGIO) have retreated approximately 43% from their 52-week high of $62.58, reported last November, and trade near the $35 level. - 2025-06-17 08:36:03
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 9,606 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO): UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) by 8.5% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 122,835 shares of the biopharmaceutical company’s stock after acquiring an additional 9,606 shares during […] - 2025-06-05 05:13:00
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Given Average Rating of “Moderate Buy” by Brokerages: Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) has earned an average recommendation of “Moderate Buy” from the eight research firms that are presently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1-year target price […] - 2025-06-04 04:52:50
Two Sigma Advisers LP Takes Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO): Two Sigma Advisers LP acquired a new stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 22,200 shares of the biopharmaceutical company’s stock, valued at approximately $729,000. A number of other […] - 2025-06-03 04:56:54
Two Sigma Investments LP Makes New $3.59 Million Investment in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO): Two Sigma Investments LP purchased a new position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) in the fourth quarter, HoldingsChannel.com reports. The firm purchased 109,373 shares of the biopharmaceutical company’s stock, valued at approximately $3,594,000. A number of other hedge funds and other institutional investors have also bought and sold shares of AGIO. Jefferies […] - 2025-05-30 05:24:59
BNP Paribas Financial Markets Lowers Stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO): BNP Paribas Financial Markets decreased its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) by 18.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,704 shares of the biopharmaceutical company’s stock after selling 2,242 shares during the quarter. BNP Paribas Financial […] - 2025-05-27 04:38:56
Agios Pharmaceuticals (NASDAQ:AGIO) Rating Lowered to Sell at StockNews.com: StockNews.com downgraded shares of Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) from a hold rating to a sell rating in a research report released on Monday morning. Several other brokerages also recently commented on AGIO. Scotiabank reduced their target price on Agios Pharmaceuticals from $74.00 to $71.00 and set a “sector outperform” rating for the company […] - 2025-05-20 02:36:56
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Stock Position Reduced by Voya Investment Management LLC: Voya Investment Management LLC cut its holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) by 48.2% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 33,007 shares of the biopharmaceutical company’s stock after selling 30,733 shares during the period. Voya Investment Management LLC’s holdings in Agios Pharmaceuticals were worth $1,085,000 as of its […] - 2025-05-07 06:32:51
Scotiabank Cuts Agios Pharmaceuticals (NASDAQ:AGIO) Price Target to $71.00: Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) had its price objective lowered by Scotiabank from $74.00 to $71.00 in a research note published on Friday morning,Benzinga reports. The firm currently has a sector outperform rating on the biopharmaceutical company’s stock. A number of other equities analysts also recently commented on AGIO. HC Wainwright assumed coverage on […] - 2025-05-05 04:38:49
CANADA LIFE ASSURANCE Co Sells 1,094 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO): CANADA LIFE ASSURANCE Co reduced its position in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) by 5.5% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 18,979 shares of the biopharmaceutical company’s stock after selling 1,094 shares during the period. CANADA LIFE ASSURANCE […] - 2025-04-30 05:48:58
Invesco Ltd. Sells 35,432 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO): Invesco Ltd. reduced its position in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) by 29.8% in the fourth quarter, HoldingsChannel reports. The firm owned 83,515 shares of the biopharmaceutical company’s stock after selling 35,432 shares during the quarter. Invesco Ltd.’s holdings in Agios Pharmaceuticals were worth $2,744,000 as of its most recent filing […] - 2025-04-29 04:25:06
Barclays PLC Sells 90,864 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO): Barclays PLC lowered its stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) by 42.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 121,753 shares of the biopharmaceutical company’s stock after selling 90,864 shares during the quarter. Barclays PLC owned approximately 0.21% […] - 2025-04-28 05:01:17
Legal & General Group Plc Sells 1,424 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO): Legal & General Group Plc lessened its position in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) by 1.9% in the fourth quarter, HoldingsChannel.com reports. The firm owned 71,677 shares of the biopharmaceutical company’s stock after selling 1,424 shares during the quarter. Legal & General Group Plc’s holdings in Agios Pharmaceuticals were worth $2,355,000 […] - 2025-04-25 05:08:57
Federated Hermes Inc. Purchases 582 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO): Federated Hermes Inc. lifted its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) by 4.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 13,691 shares of the biopharmaceutical company’s stock after buying an additional 582 shares during the period. Federated […] - 2025-04-18 04:53:04
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Receives $56.57 Consensus PT from Analysts: Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the nine research firms that are covering the stock, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 12 month […] - 2025-04-18 02:28:57
Norges Bank Takes $4.77 Million Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO): Norges Bank purchased a new stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 145,092 shares of the biopharmaceutical company’s stock, valued at approximately $4,768,000. Several other hedge funds and other institutional investors also recently added to or reduced their stakes in AGIO. NEOS Investment […] - 2025-04-10 05:02:57
Vanguard Group Inc. Grows Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO): Vanguard Group Inc. raised its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) by 1.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,631,321 shares of the biopharmaceutical company’s stock after buying an additional 85,339 shares during the […] - 2025-04-07 05:06:53
Thrivent Financial for Lutherans Sells 7,077 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO): Thrivent Financial for Lutherans decreased its holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) by 28.8% in the fourth quarter, HoldingsChannel.com reports. The fund owned 17,526 shares of the biopharmaceutical company’s stock after selling 7,077 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Agios Pharmaceuticals were worth $576,000 at the end of […] - 2025-04-04 04:32:55
Brokerages Set Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) PT at $56.57: Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the nine brokerages that are currently covering the company, Marketbeat.com reports. Four research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average twelve-month price target […] - 2025-03-26 04:57:01
Short Interest in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Decreases By 14.9%: Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) was the target of a significant drop in short interest during the month of February. As of February 28th, there was short interest totalling 3,940,000 shares, a drop of 14.9% from the February 13th total of 4,630,000 shares. Based on an average daily volume of 895,400 shares, […] - 2025-03-21 04:26:52
AlphaQuest LLC Increases Holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO): AlphaQuest LLC raised its stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) by 106.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,540 shares of the biopharmaceutical company’s stock after buying an additional 2,338 shares during the quarter. AlphaQuest […] - 2025-03-18 06:03:33
New York State Common Retirement Fund Purchases 4,663 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO): New York State Common Retirement Fund boosted its position in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) by 13.5% in the fourth quarter, Holdings Channel reports. The fund owned 39,093 shares of the biopharmaceutical company’s stock after purchasing an additional 4,663 shares during the quarter. New York State Common Retirement Fund’s holdings in […] - 2025-03-03 07:20:48
Agios Pharmaceuticals (NASDAQ:AGIO) Cut to Sell at StockNews.com: StockNews.com lowered shares of Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) from a hold rating to a sell rating in a research note issued to investors on Friday morning. A number of other research firms have also recently commented on AGIO. Cantor Fitzgerald restated an “overweight” rating on shares of Agios Pharmaceuticals in a research report […] - 2025-02-17 04:53:15

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) AGIO holdings

Date	Number of AGIO Shares Held	Base Market Value of AGIO Shares	Local Market Value of AGIO Shares	Change in AGIO Shares Held	Change in AGIO Base Value	Current Price per AGIO Share Held	Previous Price per AGIO Share Held
2025-11-12 (Wednesday)	37,372	USD 1,630,540	USD 1,630,540	96	USD -4,385	USD 43.63	USD 43.86
2025-11-11 (Tuesday)	37,276	USD 1,634,925	USD 1,634,925	0	USD 92,444	USD 43.86	USD 41.38
2025-11-10 (Monday)	37,276	USD 1,542,481	USD 1,542,481	95	USD 30,330	USD 41.38	USD 40.67
2025-11-07 (Friday)	37,181	USD 1,512,151	USD 1,512,151	0	USD 13,385	USD 40.67	USD 40.31
2025-11-06 (Thursday)	37,181	USD 1,498,766	USD 1,498,766	95	USD -3,588	USD 40.31	USD 40.51
2025-11-05 (Wednesday)	37,086	USD 1,502,354	USD 1,502,354	0	USD 18,914	USD 40.51	USD 40
2025-11-04 (Tuesday)	37,086	USD 1,483,440	USD 1,483,440	96	USD -969	USD 40	USD 40.13
2025-11-03 (Monday)	36,990	USD 1,484,409	USD 1,484,409	0	USD -115,039	USD 40.13	USD 43.24
2025-10-31 (Friday)	36,990	USD 1,599,448	USD 1,599,448	0	USD 2,220	USD 43.24	USD 43.18
2025-10-30 (Thursday)	36,990	USD 1,597,228	USD 1,597,228	480	USD 65,268	USD 43.18	USD 41.96
2025-10-29 (Wednesday)	36,510	USD 1,531,960	USD 1,531,960	192	USD -45,331	USD 41.96	USD 43.43
2025-10-28 (Tuesday)	36,318	USD 1,577,291	USD 1,577,291	0	USD 12,712	USD 43.43	USD 43.08
2025-10-27 (Monday)	36,318	USD 1,564,579	USD 1,564,579	0	USD -9,080	USD 43.08	USD 43.33

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of AGIO by Blackrock for IE00BDZVHG35

Show aggregate share trades of AGIO

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-12 BUY 96 44.550 43.200 43.335 USD 4,160 37.13
2025-11-10 BUY 95 42.070 41.000 41.107 USD 3,905 37.07
2025-11-06 BUY 95 40.860 39.940 40.032 USD 3,803 37.03
2025-11-04 BUY 96 40.320 38.900 39.042 USD 3,748 37.00
2025-10-30 BUY 480 43.810 40.180 40.543 USD 19,461 36.91
2025-10-29 BUY 192 41.960 43.470 43.319 USD 8,317 36.88
2025-10-22 SELL -384 41.740 43.540 43.360 USD -16,650 36.71 Loss of -2,553 on sale
2025-10-20 BUY 192 42.650 43.240 43.181 USD 8,291 36.64
2025-10-17 BUY 479 42.330 43.690 43.554 USD 20,862 36.60
2025-10-15 BUY 760 41.380 41.710 41.677 USD 31,675 36.58
2025-10-03 BUY 672 40.500 41.420 41.328 USD 27,772 36.53
2025-10-02 BUY 96 39.930 40.580 40.515 USD 3,889 36.51
2025-09-30 BUY 192 40.140 40.200 40.194 USD 7,717 36.47
2025-09-26 BUY 192 38.930 39.260 39.227 USD 7,532 36.43
2025-09-25 BUY 192 36.610 37.230 37.168 USD 7,136 36.43
2025-09-18 BUY 101 37.950 38.020 38.013 USD 3,839 36.42
2025-09-17 BUY 306 36.420 38.450 38.247 USD 11,704 36.42
2025-07-17 SELL -202 40.350 40.950 40.890 USD -8,260 36.35 Loss of -917 on sale
2025-07-16 BUY 707 39.990 40.040 40.035 USD 28,305 36.33
2025-07-11 SELL -792 39.050 39.910 39.824 USD -31,541 36.27 Loss of -2,815 on sale
2025-07-02 BUY 5,445 35.350 35.850 35.800 USD 194,931 36.24
2025-06-25 BUY 198 32.710 33.730 33.628 USD 6,658 36.32
2025-06-20 BUY 816 34.410 35.880 35.733 USD 29,158 36.38
2025-06-11 BUY 194 34.410 35.430 35.328 USD 6,854 36.45
2025-06-10 BUY 194 34.510 34.700 34.681 USD 6,728 36.46
2025-06-04 SELL -97 34.030 34.700 34.633 USD -3,359 36.54 Profit of 185 on sale
2025-04-23 BUY 97 28.370 29.220 29.135 USD 2,826 38.63
2025-04-10 SELL -776 25.310 25.760 25.715 USD -19,955 39.78 Profit of 10,916 on sale
2025-04-08 SELL -97 24.530 26.980 26.735 USD -2,593 40.11 Profit of 1,298 on sale
2025-04-07 SELL -97 25.900 27.090 26.971 USD -2,616 40.28 Profit of 1,291 on sale
2025-04-04 SELL -485 25.760 27.860 27.650 USD -13,410 40.45 Profit of 6,207 on sale
2025-04-01 BUY 1,172 27.400 29.350 29.155 USD 34,170 40.75
2025-03-31 SELL -282 29.300 29.830 29.777 USD -8,397 40.89 Profit of 3,134 on sale
2025-03-21 BUY 1,354 31.300 32.900 32.740 USD 44,330 41.67
2025-03-14 SELL -1,440 30.930 31.850 31.758 USD -45,732 42.37 Profit of 15,287 on sale
2025-03-07 SELL -180 32.380 34.470 34.261 USD -6,167 43.17 Profit of 1,603 on sale
2025-03-04 SELL -90 33.390 33.660 33.633 USD -3,027 43.61 Profit of 898 on sale
2025-02-25 BUY 180 35.190 35.750 35.694 USD 6,425 44.40
2025-02-19 SELL -90 34.020 34.500 34.452 USD -3,101 45.12 Profit of 960 on sale
2025-02-13 BUY 270 33.300 33.490 33.471 USD 9,037 46.07
2025-02-12 BUY 90 32.810 33.340 33.287 USD 2,996 46.34
2025-02-11 BUY 360 32.660 33.810 33.695 USD 12,130 46.62
2024-12-30 SELL -3,031 33.030 33.800 33.723 USD -102,214 52.40 Profit of 56,616 on sale
2024-11-18 SELL -1,455 52.890 54.000 53.889 USD -78,408 48.15 Loss of -8,357 on sale
2024-11-08 SELL -97 59.060 60.210 60.095 USD -5,829 46.59 Loss of -1,310 on sale
2024-10-21 SELL -98 45.660 46.050 46.011 USD -4,509 0.00 Loss of -4,509 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-12	BUY	96	44.550	43.200	43.335	USD 4,160	37.13
2025-11-10	BUY	95	42.070	41.000	41.107	USD 3,905	37.07
2025-11-06	BUY	95	40.860	39.940	40.032	USD 3,803	37.03
2025-11-04	BUY	96	40.320	38.900	39.042	USD 3,748	37.00
2025-10-30	BUY	480	43.810	40.180	40.543	USD 19,461	36.91
2025-10-29	BUY	192	41.960	43.470	43.319	USD 8,317	36.88
2025-10-22	SELL	-384	41.740	43.540	43.360	USD -16,650	36.71 Loss of -2,553 on sale
2025-10-20	BUY	192	42.650	43.240	43.181	USD 8,291	36.64
2025-10-17	BUY	479	42.330	43.690	43.554	USD 20,862	36.60
2025-10-15	BUY	760	41.380	41.710	41.677	USD 31,675	36.58
2025-10-03	BUY	672	40.500	41.420	41.328	USD 27,772	36.53
2025-10-02	BUY	96	39.930	40.580	40.515	USD 3,889	36.51
2025-09-30	BUY	192	40.140	40.200	40.194	USD 7,717	36.47
2025-09-26	BUY	192	38.930	39.260	39.227	USD 7,532	36.43
2025-09-25	BUY	192	36.610	37.230	37.168	USD 7,136	36.43
2025-09-18	BUY	101	37.950	38.020	38.013	USD 3,839	36.42
2025-09-17	BUY	306	36.420	38.450	38.247	USD 11,704	36.42
2025-07-17	SELL	-202	40.350	40.950	40.890	USD -8,260	36.35 Loss of -917 on sale
2025-07-16	BUY	707	39.990	40.040	40.035	USD 28,305	36.33
2025-07-11	SELL	-792	39.050	39.910	39.824	USD -31,541	36.27 Loss of -2,815 on sale
2025-07-02	BUY	5,445	35.350	35.850	35.800	USD 194,931	36.24
2025-06-25	BUY	198	32.710	33.730	33.628	USD 6,658	36.32
2025-06-20	BUY	816	34.410	35.880	35.733	USD 29,158	36.38
2025-06-11	BUY	194	34.410	35.430	35.328	USD 6,854	36.45
2025-06-10	BUY	194	34.510	34.700	34.681	USD 6,728	36.46
2025-06-04	SELL	-97	34.030	34.700	34.633	USD -3,359	36.54 Profit of 185 on sale
2025-04-23	BUY	97	28.370	29.220	29.135	USD 2,826	38.63
2025-04-10	SELL	-776	25.310	25.760	25.715	USD -19,955	39.78 Profit of 10,916 on sale
2025-04-08	SELL	-97	24.530	26.980	26.735	USD -2,593	40.11 Profit of 1,298 on sale
2025-04-07	SELL	-97	25.900	27.090	26.971	USD -2,616	40.28 Profit of 1,291 on sale
2025-04-04	SELL	-485	25.760	27.860	27.650	USD -13,410	40.45 Profit of 6,207 on sale
2025-04-01	BUY	1,172	27.400	29.350	29.155	USD 34,170	40.75
2025-03-31	SELL	-282	29.300	29.830	29.777	USD -8,397	40.89 Profit of 3,134 on sale
2025-03-21	BUY	1,354	31.300	32.900	32.740	USD 44,330	41.67
2025-03-14	SELL	-1,440	30.930	31.850	31.758	USD -45,732	42.37 Profit of 15,287 on sale
2025-03-07	SELL	-180	32.380	34.470	34.261	USD -6,167	43.17 Profit of 1,603 on sale
2025-03-04	SELL	-90	33.390	33.660	33.633	USD -3,027	43.61 Profit of 898 on sale
2025-02-25	BUY	180	35.190	35.750	35.694	USD 6,425	44.40
2025-02-19	SELL	-90	34.020	34.500	34.452	USD -3,101	45.12 Profit of 960 on sale
2025-02-13	BUY	270	33.300	33.490	33.471	USD 9,037	46.07
2025-02-12	BUY	90	32.810	33.340	33.287	USD 2,996	46.34
2025-02-11	BUY	360	32.660	33.810	33.695	USD 12,130	46.62
2024-12-30	SELL	-3,031	33.030	33.800	33.723	USD -102,214	52.40 Profit of 56,616 on sale
2024-11-18	SELL	-1,455	52.890	54.000	53.889	USD -78,408	48.15 Loss of -8,357 on sale
2024-11-08	SELL	-97	59.060	60.210	60.095	USD -5,829	46.59 Loss of -1,310 on sale
2024-10-21	SELL	-98	45.660	46.050	46.011	USD -4,509	0.00 Loss of -4,509 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of AGIO

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	66,908	0	122,346	54.7%
2025-09-18	107,747	0	245,827	43.8%
2025-09-17	120,521	6	236,006	51.1%
2025-09-16	96,865	7	184,380	52.5%
2025-09-15	118,459	10	164,576	72.0%
2025-09-12	70,299	0	216,181	32.5%
2025-09-11	59,764	0	205,227	29.1%
2025-09-10	86,293	0	254,457	33.9%
2025-09-09	134,717	0	222,059	60.7%
2025-09-08	152,472	1,048	281,198	54.2%
2025-09-05	402,261	2,719	568,902	70.7%
2025-09-04	724,185	13,979	1,196,899	60.5%
2025-09-03	183,410	12,130	258,807	70.9%
2025-09-02	148,082	600	204,223	72.5%
2025-08-29	73,826	100	138,702	53.2%
2025-08-28	84,013	0	148,016	56.8%
2025-08-27	205,307	0	325,310	63.1%
2025-08-26	81,476	0	172,165	47.3%
2025-08-25	106,699	0	271,700	39.3%
2025-08-22	158,363	460	219,936	72.0%
2025-08-21	171,667	900	192,102	89.4%
2025-08-20	70,628	0	91,838	76.9%
2025-08-19	215,285	0	258,851	83.2%
2025-08-18	193,961	0	235,195	82.5%
2025-08-15	79,832	0	110,711	72.1%
2025-08-14	57,294	0	82,325	69.6%
2025-08-13	112,768	0	172,693	65.3%
2025-08-12	95,468	0	145,367	65.7%
2025-08-11	132,797	0	211,978	62.6%
2025-08-08	92,144	3,366	174,430	52.8%
2025-08-07	136,944	158	178,218	76.8%
2025-08-06	262,113	118	362,072	72.4%
2025-08-05	252,723	4,006	386,830	65.3%
2025-08-04	1,234,835	19,021	2,629,492	47.0%
2025-08-01	976,822	3,396	1,054,061	92.7%
2025-07-31	367,020	0	527,359	69.6%
2025-07-30	304,028	0	365,506	83.2%
2025-07-29	157,934	1	221,901	71.2%
2025-07-28	151,657	0	237,953	63.7%
2025-07-25	139,643	22	240,961	58.0%
2025-07-24	88,686	106	205,180	43.2%
2025-07-23	209,448	2	440,983	47.5%
2025-07-22	137,870	0	376,995	36.6%
2025-07-21	96,551	0	204,504	47.2%
2025-07-18	153,114	60	261,825	58.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE